Texas bills · 89th Legislature (2025)
Texas SB 883
Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.
- Introduced
- In committee
- Passed Senate
- Passed House
- To Governor
- Became law
Sponsors
Cosponsors (2)
Summary
No official summary is available for this bill.
Latest action(Apr 22, 2025): Referred to Public Health
Text versions
Roll-call votes
State vote data last updated Oct 16, 2026, 4:04 AM.
| Date | Vote | Result | Your legislators |
|---|---|---|---|
| Apr 10, 2025 Senate | passage | pass | Set your home in Texas to see |
| Apr 10, 2025 Senate | passage | pass | Set your home in Texas to see |
Actions
- Apr 22, 2025 · House
Referred to Public Health - Apr 22, 2025 · House
Read first time - Apr 14, 2025 · House
Received from the Senate - Apr 10, 2025 · Senate
Reported engrossed - Apr 10, 2025 · Senate
Record vote - Apr 10, 2025 · Senate
Passed - Apr 10, 2025 · Senate
Read 3rd time - Apr 10, 2025 · Senate
Record vote - Apr 10, 2025 · Senate
Rules suspended-Regular order of business - Apr 10, 2025 · Senate
Record vote - Apr 10, 2025 · Senate
Read 2nd time & passed to engrossment - Apr 10, 2025 · Senate
Record vote - Apr 10, 2025 · Senate
Rules suspended-Regular order of business - Apr 10, 2025 · Senate
Co-author authorized - Apr 9, 2025 · Senate
Placed on intent calendar - Apr 7, 2025 · Senate
Committee report printed and distributed - Apr 7, 2025 · Senate
Reported favorably w/o amendments - Apr 2, 2025 · Senate
Vote taken in committee - Apr 2, 2025 · Senate
Considered in public hearing - Apr 1, 2025 · Senate
Left pending in committee - Apr 1, 2025 · Senate
Testimony taken in committee - Apr 1, 2025 · Senate
Considered in public hearing - Apr 1, 2025 · Senate
Scheduled for public hearing on . . . - Mar 20, 2025 · Senate
Co-author authorized - Feb 13, 2025 · Senate
Referred to Health & Human Services - Feb 13, 2025 · Senate
Read first time - Jan 23, 2025 · Senate
Filed - Jan 23, 2025 · Senate
Received by the Secretary of the Senate